Prophylactic Strategies and Advice for Managing AEs in Bispecific Therapies

Experts discuss prophylactic measures for managing potential adverse events associated with talquetamab and other bispecifics, while all faculty will offer advice for health care providers involved in the care of patients receiving talquetamab.

EP: 1.Overview of Relapsed/Refractory Multiple Myeloma: Diagnosis, Treatment Options, Unmeet Needs

EP: 2.MonumenTAL-1: Long Term Follow up Efficacy

EP: 3.MonumenTAL-1: Safety and AEs

EP: 4.Managing GPRC5D Therapy: Unique AE Challenges and Patient Preparation

EP: 5.Administering GPRC5D therapy: Dosing and Monitoring for CRS & ICANS

EP: 6.Managing toxicities of BCMA_targeting Bispecfics

EP: 7.Management of Oral Toxcities associated with GPRC5D Bispecifics Nail

Now Viewing

EP: 8.Prophylactic Strategies and Advice for Managing AEs in Bispecific Therapies

EP: 9.Unmet Needs and Future Perspectives on the treatment of R/R MM

Video content above is prompted by the following:

• What are some prophylactic measures taken to manage potential adverse events associated with talquetamab and other bispecifics?
• What advice do you have for other health care providers who are involved in or about to be involved in the care of patients on talquetamab?

Recent Videos